ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ascorbic acid inhibits transcriptional activities of LXRα to ameliorate lipid metabolism disorder

Wang, Dandan; Yin, Zequn; Han, Lan; Zhang, Mengxue; Li, Huaxin; Yang, Xiaoxiao; Chen, Yuanli; Zhang, Shuang; Han, Jihong*; Duan, Yajun*1
Journal of Functional Foods2022-1DOI: 10.1016/j.jff.2021.104901
2被引7阅读
引用收藏
分享

摘要

It has been reported that ascorbic acid inhibits non-alcoholic fatty liver disease partially by activating fatty acid beta-oxidation. However, little is known about the mechanism of ascorbic acid-mediated lipid synthesis. Western blot, qRT-PCR and immunofluorescent staining were used to determine if ascorbic acid can regulate expression of liver X receptor alpha (LXR alpha) and AMP-activated protein kinase alpha (AMPK alpha), which are key regulators of lipogenic genes. In hepatocytes, ascorbic acid decreased cellular lipid accumulation. Mechanistically, ascorbic acid inhibited expression of the genes for lipid synthesis by reducing LXR alpha nuclear translocation and activating AMPK alpha. In vivo, administration of ascorbic acid decreased triglyceride levels in serum and liver as well as FFA levels in the liver. Taken together, AMPK alpha/LXR alpha-mediated reduction of lipid accumulation in the liver is a novel activity of ascorbic acid on lipid metabolism, suggesting that ascorbic acid is an effective and safe dietary supplement to ameliorate hypertriglyceridemia.

学科与关键词

关键词
Ascorbic acidTriglycerideLXR alphaSREBP1cAMPK alpha
相关
加载中…
  • Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis
    Chen, Yulian; Jiang, Huanguo; Zhan, Zhikun; Lu, Jindi; Gu, Tanwei; Yu, Ping; Liang, Weimin; Zhang, Xi; Liu, Shuwen; Bi, Huichang; Zhong, Shilong*; Tang, Lan*Cell Death & Disease, 2023, 14(2): 85.被引 4
  • A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)
    Zhou, Shipeng; You, Huimin; Qiu, Shuting; Yu, Dawei; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*Biomedicine and Pharmacotherapy, 2022, 154: 113577.被引 16
  • Oridonin restores hepatic lipid homeostasis in an LXRa-ATGL/EPT1 axis-dependent manner
    Chen, Yulian; Jiang, Huanguo; Zhan, Zhikun; Lu, Jindi; Gu, Tanwei; Yu, Ping; Liang, Weimin; Zhang, Xi; Zhong, Shilong; Tang, Lan*Journal of Pharmaceutical Analysis, 2023, 13(11): 1281-1295.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Functional Foods
发表日期
2022-01
卷期
第 88 卷
页码
104901
DOI
10.1016/j.jff.2021.104901
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81722046, 81973316, 81773727, 81803517, 31770863]; Fundamental Research Funds for the Central Universities

作者

  • W

    Wang, Dandan (第一作者)

    anhui univ

  • Y

    Yin, Zequn

查看全部 10 位作者收起作者
  • H

    Han, Lan

    anhui univ

  • Z

    Zhang, Mengxue

  • L

    Li, Huaxin

  • Y

    Yang, Xiaoxiao

  • C

    Chen, Yuanli

  • Z

    Zhang, Shuang

  • H

    Han, Jihong (通讯)

  • D

    Duan, Yajun (通讯)

    1 · univ sci & technol china

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417